CoinGecko, a cryptocurrency data and tracking platform, has shared the most searched altcoins on its platform in the last three hours. According to the list, memecoins with low market cap and AI-focused projects have been attracting significant investor interest recently.
According to CoinGecko data, Solayer (LAYER), which ranks first on the list, recorded a 55.8% increase in the last 24 hours, while TROLL, in second place, attracted attention with a 76.4% increase. Billions Network (BILL), in third place, gained 17.6% in value during the same period.
Related News: Experienced Analyst Identifies Two Resistance Levels for Bitcoin - “A Similar Pattern Has Been Seen Three Times Before in History”
According to the latest data shared by CoinGecko, the most searched altcoins and their total market capitalization are ranked as follows:
- Solayer (LAYER) – $30.08 million
- TROLL – $91.23 million
- Billions Network (BILL) – $265.14 million
- WOJAK – $37.05 million
- Zcash (ZEC) – $10.21 billion
- LAB (LAB) – $382.09 million
- Venice Token (VVV) – $698.51 million
- Monad (MON) – $407.12 million
- Solana (SOL) – $54.23 billion
- Ondo (ONDO) – $1.98 billion
- Arbitrum (ARB) – $876.67 million
- OpenGradient (OPG) – $53.79 million
- Jupiter (JUP) – $827.95 million
- Arweave (AR) – $164.60 million
- Dogecoin (DOGE) – $16.77 billion
*This is not investment advice.
Continue Reading: List of the Most-Searched Altcoins in Recent Hours Released – This Time, There’s an Unusual Pattern
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.